MedSci Healthcare Holdings Limited (HKG:2415)
Hong Kong · Delayed Price · Currency is HKD 1.480
0.00 (0.00%)
At close: Oct 30, 2025
HKG:2415 Revenue
MedSci Healthcare Holdings had revenue of 125.25M CNY in the half year ending June 30, 2025, a decrease of -17.27%. This brings the company's revenue in the last twelve months to 275.20M, down -10.78% year-over-year. In the year 2024, MedSci Healthcare Holdings had annual revenue of 260.62M, down -25.36%.
Revenue (ttm)
275.20M CNY
Revenue Growth
-10.78%
P/S Ratio
2.65
Revenue / Employee
563.94K CNY
Employees
488
Market Cap
800.21M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 260.62M | -88.57M | -25.36% |
| Dec 31, 2023 | 349.19M | 244.00K | 0.07% |
| Dec 31, 2022 | 348.95M | 51.22M | 17.20% |
| Dec 31, 2021 | 297.73M | 81.88M | 37.93% |
| Dec 31, 2020 | 215.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 35.81B |
| Sino Biopharmaceutical | 33.49B |
| Alibaba Health Information Technology | 32.81B |
| CSPC Pharmaceutical Group | 28.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |